Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury-Reference-Cited by-同舟云学术

Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury

Published:2013-02 Issue:2 Volume:57 Page:727-739
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Monshi Manal M.,Faulkner Lee,Gibson Andrew,Jenkins Rosalind E.,Farrell John,Earnshaw Caroline J.,Alfirevic Ana,Cederbrant Karin,Daly Ann K.,French Neil,Pirmohamed Munir,Park B. Kevin,Naisbitt Dean J.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26077/fullpdf

Reference28 articles.

1. Managing the challenge of chemically reactive metabolites in drug development;Park;Nat Rev Drug Discov,2011

2. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir;Mallal;Lancet,2002

3. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans;McCormack;N Engl J Med,2011

4. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population;Ozeki;Hum Mol Genet,2011

5. Medical genetics: a marker for Stevens-Johnson syndrome;Chung;Nature,2004

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA-B*35:01-mediated activation of emodin-specific T cells contributes to Polygonum multiflorum thunb. -induced liver injury in mice;Journal of Ethnopharmacology;2024-11

2. Posttranslationally modified self-peptides promote hypertension in mouse models;Journal of Clinical Investigation;2024-08-15

3. A challenging case of drug-induced cholestatic liver injury: How to approach?;2024-08-05

4. Clues of HLAs, metabolic SNPs, and epigenetic factors in T cell-mediated drug hypersensitivity reactions;Heliyon;2024-07

5. Elucidating the Mechanisms Underlying Interindividual Differences in the Onset of Adverse Drug Reactions;Biological and Pharmaceutical Bulletin;2024-06-01